Related Experiment Video
Updated: Jan 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Protein Kinase Expression of the AKT/mTOR Signaling Pathway in Peripheral Mononuclear Cells of Schizophrenia
Anastasiia S Boiko1, Ekaterina V Mikhalitskaya1, Elena G Kornetova1
1Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Aleutskaya Str., 4, 634014 Tomsk, Russia.
Abstract:
A comprehensive study of the contribution of dysfunction AKT/mTOR signaling to the pathogenesis of schizophrenia is needed. The aim of the study is to determine the expression of the protein kinase AKT/mTOR signaling pathway in peripheral mononuclear cells (PMCs) of patients with schizophrenia. Determination of AKT1, mTOR, p70S6K, GSK3-α, and GSK3-β in mononuclears was performed on multiplex analyzers. Statistical data processing was carried out using SPSS. The critical significance level for the differences was 0.05. The study included 58 patients with schizophrenia (F20) and 60 healthy individuals. We found an increase in the expression of AKT1 and p706SK in PM׳s of patients (p = 0.006, p = 0.001). Analysis of kinase expression was carried out depending on clinical characteristics (type of course, leading symptoms and duration of the schizophrenia). Increased expression of GSK3-α and GSK3-β was detected in patients with a duration of disease more than 5 years (p = 0.019, p = 0.018). The AKT/mTOR signaling cascade may play a significant role in the pathogenesis of schizophrenia. We can assume that signaling pathways are involved in neurobiological processes and can be targets for new methods of pharmacotherapy, prognosis and diagnosis of mental disorders.
Insights
Dysfunctional AKT/mTOR signaling, particularly increased AKT1 and p70S6K expression, is linked to schizophrenia pathogenesis. This suggests signaling pathways as potential targets for treating this mental disorder.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Schizophrenia pathogenesis requires further investigation into molecular signaling pathways.
- The AKT/mTOR signaling cascade's role in mental disorders is not fully understood.
Purpose of the Study:
- To investigate the expression of the AKT/mTOR signaling pathway in peripheral mononuclear cells (PMCs) of schizophrenia patients.
- To correlate kinase expression with clinical characteristics of schizophrenia.
Main Methods:
- Multiplex analysis was used to determine the expression of AKT1, mTOR, p70S6K, GSK3-α, and GSK3-β in PMCs.
- Statistical analysis was performed using SPSS with a significance level of 0.05.
- The study included 58 schizophrenia patients (F20) and 60 healthy controls.
Main Results:
- Significantly increased expression of AKT1 (p=0.006) and p70S6K (p=0.001) was observed in the PMCs of schizophrenia patients.
- Elevated GSK3-α (p=0.019) and GSK3-β (p=0.018) expression was found in patients with schizophrenia duration exceeding 5 years.
Conclusions:
- The AKT/mTOR signaling cascade appears to play a significant role in the pathogenesis of schizophrenia.
- These signaling pathways may serve as crucial targets for novel pharmacotherapy, prognosis, and diagnostic approaches in mental disorders.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway